AC Immune - 53 Year Dividend History | ACIU
Historical dividend payout and yield for AC Immune (ACIU) since 1971. The current TTM dividend payout for AC Immune (ACIU) as of November 19, 2024 is $0.00. The current dividend yield for AC Immune as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.324B |
$0.016B |
|
AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn which are in clinical trial. AC Immune SA is based in Lausanne, Switzerland.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
